-
241
Molecular Imaging Probes for Diagnosis and Therapy Evaluation of Breast Cancer
Published 2013-01-01“…Molecular imaging has the potential to enhance our understanding of breast cancer biology and effects of drug action during both preclinical and clinical phases of drug development. …”
Get full text
Article -
242
The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination
Published 2012-01-01“…Despite extensive preclinical evidence that peroxisome proliferator-activated receptor (PPAR)γ activation protects against tumourigenesis, results from a few clinical trials using PPARγ ligands as monotherapy show modest success. …”
Get full text
Article -
243
Application of Surface Roughness Analysis on Micro–Computed Tomographic Images of Bone Erosion: Examples Using a Rodent Model of Rheumatoid Arthritis
Published 2006-10-01“…Quantifying the bone erosion in preclinical models of rheumatoid arthritis is valuable for the evaluation of drug treatments. …”
Get full text
Article -
244
Practical Vessel Imaging by Computed Tomography in Live Transgenic Mouse Models for Human Tumors
Published 2005-10-01“…This study lays a groundwork for the qualitative and quantitative assessment of anti-angiogenesis preclinical studies using transgenic mice.…”
Get full text
Article -
245
Mesenchymal Stem Cells and Cutaneous Wound Healing: Current Evidence and Future Potential
Published 2015-01-01“…This review examines the body of evidence suggesting that MSC accelerate wound healing in both clinical and preclinical studies and also the possible mechanisms controlling its efficacy. …”
Get full text
Article -
246
Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy
Published 2023-01-01“…The complexity of cancer immunotherapy (CIT) demands reliable preclinical models to successfully translate study findings to the clinics. …”
Get full text
Article -
247
Measuring Brain Tumor Growth: Combined Bioluminescence Imaging–Magnetic Resonance Imaging Strategy
Published 2009-09-01“…The results led us to suggest a cost-effective, multimodality strategy for selecting cohorts of animals with similar tumor growth patterns that improves the accuracy of longitudinal in vivo measurements of tumor growth and treatment response in preclinical therapeutic studies.…”
Get full text
Article -
248
Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
Published 2019-01-01“…Accordingly, several strategies have been explored to improve MSC retention in the lung and enhance the innate properties of MSCs in preclinical models of ARDS. To provide a comprehensive and updated view, we summarize a large body of experimental evidence for a variety of strategies directed towards strengthening the therapeutic potential of MSCs in ARDS.…”
Get full text
Article -
249
Recent Advances, Research Trends, and Clinical Relevance of Hyaluronic Acid Applied to Wound Healing and Regeneration
Published 2025-01-01“…This review reports many of the latest developments of hyaluronan and its derivatives in research, preclinical, and published clinical trials for wound healing. …”
Get full text
Article -
250
-
251
African animal trypanocide resistance: A systematic review and meta-analysis
Published 2023“…To address resistance, most preclinical studies increased the dosage and the treatment time, and this failed to improve the patient’s prognosis. …”
Get full text
Article -
252
Comparison Study of Airway Reactivity Outcomes due to a Pharmacologic Challenge Test: Impulse Oscillometry versus Least Mean Squared Analysis Techniques
Published 2013-01-01“…The present study represents a preclinical animal study to determine whether these respiratory function techniques (LMS and IOS) are comparable in detecting changes in respiratory resistance derived from a direct pharmacological challenge.…”
Get full text
Article -
253
Epigenetic Drug Interventions in Breast Cancer: A Narrative Review of Current Research and Future Directions
Published 2024-09-01“…In this review, we summarise and present the preclinical and clinical evidence for epigenetic drugs in treating breast cancer. …”
Get full text
Article -
254
Oligonucleotides as a Novel Therapeutic Approach: An Innovative Area for Drug Delivery in Neurological Disorders
Published 2025-01-01“…The current review provides an update on novel approaches, preclinical, clinical evidence, and delivery route of ASOs. …”
Get full text
Article -
255
The Potential of Curcumin in Treatment of Spinal Cord Injury
Published 2016-01-01“…We critically and systematically summarize available data, discuss clinical implications, and propose further testing of this well-tolerated compound in both the preclinical and the clinical realms. Analyzing preclinical data from a clinical perspective, we hope to create awareness of the incredible potential that curcumin shows for SCI in a patient population that direly needs improvements on current therapy.…”
Get full text
Article -
256
Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges
Published 2016-01-01“…In anticipation of phase III trial results which may potentially signify a significant step in achieving market approval here, we review the preclinical and clinical emergence of sclerostin antibody therapies for both osteoporosis and alternative applications. …”
Get full text
Article -
257
Hubungan antara Kebiasaan Olahraga dengan Dismenore pada Mahasiswi Pre-Klinik Program Studi Pendidikan Dokter Fakultas Kedokteran Universitas Andalas Tahun Ajaran 2012 - 2013
Published 2015-09-01“…The population of this study were all female preclinical students of Medical Faculty Andalas University in academic<br />year 2012-2013. …”
Get full text
Article -
258
Establishment and characterization of a new mouse gastric carcinoma cell line, MCC
Published 2025-01-01“…By integrating proteomic profiles from clinical gastric cancer patients and the murine subcutaneous tumor model, several molecular targets suitable for preclinical investigation were identified. Trametinib, a MEK inhibitor, was employed as a model compound in our preclinical study. …”
Get full text
Article -
259
Interactions of miR-34b/c and TP53 Polymorphisms on the Risk of Intracranial Aneurysm
Published 2012-01-01Get full text
Article -
260
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Published 2025-01-01“…Notably, cancer-associated fibroblasts (CAFs) have emerged as one of the primary contributors in shaping TME, creating a favourable environment for cancer development. Many preclinical studies have identified promising targets on CAFs, demonstrating remarkable efficacy of some CAF-targeted treatments in preclinical models. …”
Get full text
Article